GT
BMY icon

Greenleaf Trust’s Bristol-Myers Squibb BMY Stock Holding History

Greenleaf Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Sell
21,894
-615
-3% -$35.3K 0.01% 306
2026
Q1 		$1.37M Buy
22,509
+2,568
+13% +$150K 0.01% 272
2025
Q4 		$1.08M Sell
19,941
-1,899
-9% -$91.4K 0.01% 318
2025
Q3 		$985K Sell
21,840
-4,363
-17% -$204K 0.01% 328
2025
Q2 		$1.21M Sell
26,203
-4,976
-16% -$244K 0.01% 276
2025
Q1 		$1.9M Buy
31,179
+1,002
+3% +$58.4K 0.02% 209
2024
Q4 		$1.71M Buy
30,177
+4,576
+18% +$256K 0.02% 221
2024
Q3 		$1.32M Buy
25,601
+9,001
+54% +$422K 0.01% 279
2024
Q2 		$689K Sell
16,600
-17,143
-51% -$767K 0.01% 389
2024
Q1 		$1.83M Sell
33,743
-20,148
-37% -$1.03M 0.02% 193
2023
Q4 		$2.77M Sell
53,891
-19,419
-26% -$1.02M 0.03% 137
2023
Q3 		$4.25M Buy
73,310
+5,305
+8% +$325K 0.05% 95
2023
Q2 		$4.35M Sell
68,005
-4,457
-6% -$299K 0.05% 95
2023
Q1 		$5.02M Buy
72,462
+3,027
+4% +$213K 0.06% 88
2022
Q4 		$5M Buy
69,435
+5,870
+9% +$443K 0.06% 87
2022
Q3 		$4.52M Buy
63,565
+13,711
+28% +$995K 0.07% 83
2022
Q2 		$3.84M Buy
49,854
+10,328
+26% +$787K 0.06% 87
2022
Q1 		$2.89M Buy
39,526
+11,430
+41% +$767K 0.03% 104
2021
Q4 		$1.75M Sell
28,096
-9,895
-26% -$580K 0.02% 153
2021
Q3 		$2.25M Sell
37,991
-1,169
-3% -$77K 0.03% 107
2021
Q2 		$2.62M Buy
39,160
+2,611
+7% +$170K 0.03% 104
2021
Q1 		$2.31M Buy
36,549
+1,776
+5% +$110K 0.03% 104
2020
Q4 		$2.16M Buy
34,773
+3,843
+12% +$236K 0.03% 102
2020
Q3 		$1.86M Buy
30,930
+867
+3% +$52.2K 0.03% 106
2020
Q2 		$1.77M Buy
30,063
+30
+0.1% +$1.79K 0.03% 103
2020
Q1 		$1.67M Sell
30,033
-12,766
-30% -$780K 0.03% 94
2019
Q4 		$2.75M Buy
42,799
+23,523
+122% +$1.35M 0.04% 86
2019
Q3 		$977K Buy
19,276
+4,659
+32% +$219K 0.02% 165
2019
Q2 		$663K Sell
14,617
-189
-1% -$8.8K 0.01% 225
2019
Q1 		$706K Sell
14,806
-3,149
-18% -$157K 0.01% 200
2018
Q4 		$933K Sell
17,955
-98
-0.5% -$5.26K 0.02% 169
2018
Q3 		$1.12M Buy
18,053
+2,050
+13% +$122K 0.02% 156
2018
Q2 		$886K Sell
16,003
-1,512
-9% -$81.7K 0.02% 174
2018
Q1 		$1.11M Buy
17,515
+1,464
+9% +$94.2K 0.02% 140
2017
Q4 		$984K Buy
16,051
+1,724
+12% +$108K 0.02% 154
2017
Q3 		$913K Buy
14,327
+4,719
+49% +$276K 0.02% 155
2017
Q2 		$535K Buy
9,608
+39
+0.4% +$2.12K 0.01% 187
2017
Q1 		$520K Buy
9,569
+742
+8% +$40.7K 0.01% 154
2016
Q4 		$516K Buy
+8,827
New +$483K 0.01% 133
2016
Q3 		– Sell
-3,775
Closed -$278K – 210
2016
Q2 		$278K Buy
3,775
+127
+3% +$8.97K 0.01% 145
2016
Q1 		$233K Sell
3,648
-517
-12% -$32.6K 0.01% 148
2015
Q4 		$287K Sell
4,165
-1,055
-20% -$69.7K 0.01% 140
2015
Q3 		$309K Buy
5,220
+1,055
+25% +$66.9K 0.01% 137
2015
Q2 		$277K Buy
4,165
+655
+19% +$43.2K 0.01% 133
2015
Q1 		$226K Sell
3,510
-384
-10% -$24K 0.01% 145
2014
Q4 		$230K Buy
+3,894
New +$220K 0.01% 142
2014
Q2 		– Sell
-14,439
Closed -$750K – 154
2014
Q1 		$750K Sell
14,439
-923
-6% -$49.1K 0.02% 91
2013
Q4 		$816K Buy
15,362
+55
+0.4% +$2.8K 0.03% 89
2013
Q3 		$708K Sell
15,307
-395
-3% -$17.3K 0.03% 91
2013
Q2 		$702K Buy
+15,702
New +$682K 0.03% 92

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Greenleaf Trust's BMY Position: Q2 2026 in Review

Greenleaf Trust reduced its Bristol-Myers Squibb (BMY) stake by 2.7% in Q2 2026, selling an estimated $35.3K and leaving 21,894 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #306.

Greenleaf Trust first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $5.02M in Q1 2023. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Greenleaf Trust held 21,894 shares of Bristol-Myers Squibb worth $1.26M as of Q2 2026.
  • Greenleaf Trust sold 615 Bristol-Myers Squibb shares in Q2 2026, an estimated $35.3K.
  • Bristol-Myers Squibb made up 0.01% of Greenleaf Trust's portfolio in Q2 2026, its #306 holding.
  • Greenleaf Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
  • Greenleaf Trust's Bristol-Myers Squibb position peaked at $5.02M in Q1 2023.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.